Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
3.230
+0.050 (1.57%)
Nov 21, 2024, 4:00 PM EST - Market closed
Daré Bioscience Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 28 | 30 | 70 | 153 | 55 | 16 | |
| Market Cap Growth | -39.00% | -56.74% | -54.04% | 178.42% | 240.92% | 98.88% | |
| Enterprise Value | 23 | 17 | 31 | 108 | 50 | 14 | |
| Last Close Price | 3.23 | 3.71 | 9.96 | 24.00 | 16.08 | 9.84 | |
| PS Ratio | 14.28 | 10.85 | 7.04 | - | - | - | |
| PB Ratio | -18.65 | -6.03 | 6.34 | 3.95 | -47.78 | 36.61 | |
| P/TBV Ratio | - | - | 6.34 | 3.95 | - | 36.61 | |
| EV/Sales Ratio | 12.07 | 5.97 | 3.06 | - | - | - | |
| Debt / Equity Ratio | -3.97 | -0.28 | 0.04 | 0.01 | -0.66 | 1.82 | |
| Asset Turnover | 0.09 | 0.09 | 0.20 | - | - | - | |
| Quick Ratio | 0.89 | 0.56 | 1.15 | 3.29 | 0.67 | 0.95 | |
| Current Ratio | 1.14 | 0.86 | 1.36 | 3.44 | 0.91 | 1.15 | |
| Return on Equity (ROE) | - | -994.69% | -124.12% | -205.82% | - | -398.02% | |
| Return on Assets (ROA) | -66.79% | -59.02% | -39.38% | -77.08% | -228.45% | -117.43% | |
| Return on Capital (ROIC) | -1243.91% | -482.87% | -77.49% | -126.42% | -4046.95% | -225.04% | |
| Earnings Yield | -12.85% | -99.03% | -43.96% | -25.26% | -49.80% | -88.37% | |
| FCF Yield | -30.76% | -129.65% | -25.78% | -18.78% | -45.89% | -82.50% | |
| Buyback Yield / Dilution | -16.28% | -3.23% | -38.29% | -103.23% | -93.15% | -45.16% | |
| Total Shareholder Return | -16.28% | -3.23% | -38.29% | -103.23% | -93.15% | -45.16% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.